# of Displayed Technologies: 10 / 204

Applied Category Filter (Click To Remove): Clinical Area


Categories

Label-Free Raman Imaging for Early Detection of Disease Remodeling
TS-076401 — Many progressive diseases, including cardiac, neurological, and other chronic disorders, begin with subtle molecular and cellular changes long before conventional clinical signs become detectable. Current diagnostic approaches generally identify disease only after significant tissue remodeling or …
  • College: College of Engineering (COE)
  • Inventors: Veeraraghavan, Rengasayee; Ammon, Madison; Radwanski, Przemyslaw; Selimi, Zoja
  • Licensing Officer: Ashouripashaki, Mandana

A Combined Negative Pressure Wound Therapy (NPWT) and Fluid Instillation Device for Open Abdomen Applications
TS-076286 — Literature shows that Negative Pressure Wound Therapy (NPWT) combined with fluid instillation can improve abdominal trauma patient outcomes. Current standards of practice are inefficient, involving assembly and off-label use of at least 8 medical products. This is further complicated by varied pro…
  • College: College of Engineering (COE)
  • Inventors: Thakkar, Neil; Eichaker, Lauren; Eppers, Daelyn; Juarez, Angelo; Le, Anna; Mathew, Joel; Mihalich, James; Nocera, Tanya; Steere, Camryn
  • Licensing Officer: Sharick, Joe

Therapeutic use of apohemoglobin-haptoglobin complexes to treat hemolysis and as a drug carrier for targeting CD163+ macrophages and monocytes
TS-075261 — Problem Hemolysis, the process by which the red blood cell membrane ruptures, releasing hemoglobin (Hb), is typically managed in mammalian organisms by intrinsic proteins such as hemopexin (Hpx) and haptoglobin (Hp). However, their concentrations in plasma are very limited, so, in conditions with s…
  • College: College of Engineering (COE)
  • Inventors: Susin Pires, Ivan; Cabrales, Pedro; Palmer, Andre
  • Licensing Officer: Schworer, Adam

Novel Natural Product Derivatives Treating Chronic Metabolic and Inflammatory Diseases
TS-075260 — Problem Type 2 diabetes and related metabolic disorders affect hundreds of millions of patients and are frequently accompanied by chronic inflammation, which accelerates disease progression and complications. Existing antidiabetic therapies often fail to adequately address inflammatory pathways and…
  • College: College of Pharmacy
  • Inventors: Carcache de Blanco, Esperanza; Anaya Eugenio, Gerardo David; Eggers, Nicole
  • Licensing Officer: He, Panqing

Endothelial Biomarkers for Detecting Neurological Diseases
TS-075259 — More than a billion people worldwide suffer from some form of neurological disorder, such as Alzheimer's (AD), Parkinson's (PD), multiple sclerosis, traumatic brain injury, epilepsy, stroke, or spinal injury. These conditions result in more than 7 million deaths, with associated costs exceed…
  • College: College of Medicine (COM)
  • Inventors: Al Tarawneh, Rawan
  • Licensing Officer: Willson, Christopher

OSU-ERβ-012: a novel ER-beta agonist for immunomodulation in chronic heart failure
TS-075258 — PROBLEM Chronic heart failure following myocardial infarction (MI) afflicts ~6.7 million US adults and is driven by maladaptive immune activation, particularly persistent activation and proliferation of CD4+ T cells. Existing anti-inflammatory and immunomodulatory approaches have largely failed to …
  • College: College of Medicine (COM)
  • Inventors: Bansal, Shyam; Gumina, Richard
  • Licensing Officer: He, Panqing

Compositions and Methods for Treating Neurological Disorders
TS-075255 — Problem The limited regenerative capacity of adult CNS neurons upon transection results in chronic neurological disability. There is an urgent need to develop novel therapies that facilitate CNS axon regeneration and ultimately restore lost neurological functions. Solution Applications Advan…
  • College: College of Medicine (COM)
  • Inventors: Segal, Benjamin; Sas, Andrew
  • Licensing Officer: Bhatti, Hamid

A small-molecule USP30 inhibitor protects against doxorubicin-induced cardiomyopathy
TS-075254 — Problem Cardiomyopathy weakens the heart muscle and impairs its ability to pump blood effectively, often leading to heart failure or sudden cardiac death. While doxorubicin remains an essential component of many cancer regimens, its use is limited by the risk of causing lethal cardiomyopathy. A maj…
  • College: College of Medicine (COM)
  • Inventors: Sun, Nuo; Krigman, Judith; Yang, Mingchong; Zhang, Ruohan
  • Licensing Officer: Willson, Christopher

Exosomal proteins as novel biomarkers for early detection of ovarian cancer
TS-075248 — Problem High-grade serous ovarian cancer (HGSOC) accounts for over 75% of all epithelial OC and has a high mortality rate due to a lack of early detection methods. Current biomarkers have low sensitivity and specificity in early-stage disease. There is an urgent need for a more effective diagnosis …
  • College: College of Medicine (COM)
  • Inventors: Karuppaiyah, Selvendiran; Cohn, David
  • Licensing Officer: Taysavang, Panya

OSU-ERβ-012 suppresses the inflammatory response in Systemic Lupus Erythematosus
TS-075247 — PROBLEM Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple organ damage, affecting women at a 9:1 rate as compared to men. The etiology of SLE is complex and incompletely understood; however, the susceptibility of women during the years in which estrogen levels ar…
  • College: College of Medicine (COM)
  • Inventors: Jarjour, Wael
  • Licensing Officer: He, Panqing

Show More Technologies

Loading icon